Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Question for Phantom (and also opinions of others): Even if good data news comes out before end of year and even if MRKR can get share price above $1 before end of year ... wouldn't we be better off "In The Long Run" if we do a reverse split anyway?
If they do a 1 for 20 RS, we go from having 84 million shares to just 4 million shares, and wouldn't having 4 mil instead of 84 mil make it alot harder for short sellers to short in the future (which we KNOW they will again as soon as MRKR reports good data news and thus the share price goes up), just simply because they would be 20 times less shares available to short?
No share holder will lose a single penny if they do a RS as the value of your shares after the RS is the exact same value of your shares before the RS.
.
And also, wouldn't having a 20 times higher share price make it easier to do a cash raise dilution if that is needed in the future?
And, wouldn't having a 20 times higher share price make it easier and more likely that Mutual funds would be able to (by their bylaws) add MRKR to their portfolio?

Thanks to you and all in advance.